Status | Study |
Terminated |
Study Name: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis Condition: Leishmaniasis, Cutaneous Date: 2010-06-07 Interventions: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |
Completed |
Study Name: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama Condition: Leishmaniasis, Cutaneous Date: 2010-03-08 Interventions: Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream) |
Completed |
Study Name: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2010-01-13 Interventions: Drug: Liposomal meglumine antimoniate (Glucantime) |
Completed |
Study Name: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) Condition: Leishmaniasis, Cutaneous Date: 2009-12-14 Interventions: Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream) |
Completed |
Study Name: Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2009-02-08 Interventions: Procedure: Photodynamic therapy |
Terminated |
Study Name: Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony Condition: Cutaneous Leishmaniasis Date: 2009-01-28 Interventions: Drug: Miltefosine and antimony |
Completed |
Study Name: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World Condition: Cutaneous Leishmaniasis Date: 2008-06-20 Interventions: Drug: WR 279,396 A topical cre |
Terminated |
Study Name: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2008-05-20 Interventions: Drug: Glucantime® 15mg Sb |
Completed |
Study Name: Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2008-05-07 Interventions: Drug: Miltefosine + Imiquimod |
Completed |
Study Name: Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) Condition: Cutaneous Leishmaniasis Date: 2008-01-21 Interventions: Drug: WR 279,396 topical cream |